Cybin to Buy Clinical Trial From Entheon Biomedical to Advance Development of CYB004

MT NewswiresJun 7, 2022 10:01 ET

BRIEF-Cybin Acquires Dmt Clinical Study From Entheon Biomedical

reutersJun 7, 2022 09:05 ET

Cybin Acquires DMT Clinical Study From Entheon Biomedical For C$1M

Benzinga Real-time NewsJun 7, 2022 08:10 ET

Entheon Biomedical Announces Non-Brokered Private Placement Financing

Benzinga Real-time NewsApr 5, 2022 15:46 ET

Entheon Biomedical Announces Expanded Psychedelics Genetic Test Panel, New Clinical Research Platform

MT NewswiresMar 29, 2022 13:51 ET

Entheon Biomedical begins enrollment in phase 1 study of DMT for addiction disorders

Seeking AlphaMar 15, 2022 11:06 ET